Hospital Universitario de Basurto-ko ikertzaileekin lankidetzan egindako argitalpenak (26)

2023

  1. Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment

    Pharmaceutics, Vol. 15, Núm. 8

  2. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

  3. The transition to Schizophrenia spectrum disorder from a first psychotic episode that did or did not appear to be induced by substance use

    Psychiatry Research, Vol. 328

2022

  1. Attachment anxiety as mediator of the relationship between childhood trauma and personality dysfunction in borderline personality disorder

    Clinical Psychology and Psychotherapy, Vol. 29, Núm. 2, pp. 501-511

  2. Diagnostic stability in substance-induced psychosis

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 4, pp. 272-280

2021

  1. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

  2. Factors influencing the effect of aripiprazole on prolactin levels in patients treated with risperidone or paliperidone. Sex seems to matter

    Schizophrenia Research, Vol. 228, pp. 382-384

  3. Proportion and predictors of remission and recovery in first-episode psychosis: Systematic review and meta-analysis

    European Psychiatry, Vol. 64, Núm. 1

2020

  1. Genetic modulation of facial emotion recognition in borderline personality disorder

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 99

  2. Intrusion errors during verbal fluency task in amyotrophic lateral sclerosis

    PLoS ONE, Vol. 15, Núm. 5

2019

  1. GAD1 gene polymorphisms are associated with bipolar I disorder and with blood homovanillic acid levels but not with plasma GABA levels

    Neurochemistry International, Vol. 124, pp. 152-161

2018

  1. Subjective Dimension of Cognitive Deficit in People With Schizophrenia and Schizoaffective Disorder

    American Journal of Psychiatric Rehabilitation, Vol. 21, Núm. 1-2, pp. 16-32

  2. The COMT Val158Met polymorphism exerts a common influence on avoidant attachment and inhibited personality, with a pattern of positive heterosis

    Psychiatry Research

2016

  1. COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients

    Pharmacogenomics, Vol. 17, Núm. 8, pp. 837-851

2015

  1. Undertreatment of human immunodeficiency virus in psychiatric inpatients: A cross-sectional study of seroprevalence and associated factors

    Neuropsychiatric Disease and Treatment, Vol. 11, pp. 1421-1426

2014

  1. Eating disorders: Predictors of change in the quality of life of caregivers

    Psychiatry Research, Vol. 215, Núm. 3, pp. 718-726

2013

  1. The Influence of the Val158Met Catechol-O-Methyltransferase Polymorphism on the Personality Traits of Bipolar Patients

    PLoS ONE, Vol. 8, Núm. 4

2012

  1. Perspectivas de los pacientes diagnosticados de depresión y atendidos por médicos de familia y psiquiatras

    Atencion Primaria, Vol. 44, Núm. 10, pp. 595-602

2011

  1. Variability of plasma homovanillic acid over 13 months in patients with Schizophrenia; Relationship with the clinical response and the wisconsin card sort test

    Neurochemical Research, Vol. 36, Núm. 8, pp. 1336-1343

2010

  1. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients

    Neurochemistry International, Vol. 56, Núm. 6-7, pp. 774-779